Clinical Trial Update: A Clinical Study of Regorafenib in Participants Who Have Been Treated in Previous Bayer-sponsored Regorafenib Studies That Have Been Completed [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update of regorafenib in participants previously treated in Bayer-sponsored regorafenib studies; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Cancer

Drugs mentioned

• Regorafenib (regorafenib)

Snippet

Sponsor: Bayer | Conditions: Solid Cancer | Phase 2 | Status: COMPLETED | Results posted: 2024-04-02